TSE: 4502 Committed to Growth & Shareholder Returns FY2025 Q2 Earnings Announcement October 30th, 2025 Important Notice For the purposes of this notice, "presentation" means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this presentation. This presentation (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does no ...